table of content
1 Study Coverage
1.1 Recombinant Hepatitis B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Market by Application
1.3.1 Global Recombinant Hepatitis B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Hepatitis B Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Hepatitis B Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Hepatitis B Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Hepatitis B Vaccine Sales by Region
2.4.1 Global Recombinant Hepatitis B Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Hepatitis B Vaccine by Region (2023-2028)
2.5 Global Recombinant Hepatitis B Vaccine Revenue by Region
2.5.1 Global Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022)
2.5.2 Global Recombinant Hepatitis B Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Hepatitis B Vaccine Sales by Manufacturers
3.1.1 Global Top Recombinant Hepatitis B Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Hepatitis B Vaccine in 2021
3.2 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers
3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Hepatitis B Vaccine Revenue in 2021
3.3 Global Recombinant Hepatitis B Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Hepatitis B Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Hepatitis B Vaccine Sales by Type
4.1.1 Global Recombinant Hepatitis B Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Hepatitis B Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Hepatitis B Vaccine Revenue by Type
4.2.1 Global Recombinant Hepatitis B Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Hepatitis B Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Hepatitis B Vaccine Price by Type
4.3.1 Global Recombinant Hepatitis B Vaccine Price by Type (2017-2022)
4.3.2 Global Recombinant Hepatitis B Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Hepatitis B Vaccine Sales by Application
5.1.1 Global Recombinant Hepatitis B Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Hepatitis B Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Hepatitis B Vaccine Revenue by Application
5.2.1 Global Recombinant Hepatitis B Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Hepatitis B Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Hepatitis B Vaccine Price by Application
5.3.1 Global Recombinant Hepatitis B Vaccine Price by Application (2017-2022)
5.3.2 Global Recombinant Hepatitis B Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Hepatitis B Vaccine Market Size by Type
6.1.1 North America Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
6.1.2 North America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
6.2 North America Recombinant Hepatitis B Vaccine Market Size by Application
6.2.1 North America Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
6.2.2 North America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
6.3 North America Recombinant Hepatitis B Vaccine Market Size by Country
6.3.1 North America Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
6.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Hepatitis B Vaccine Market Size by Type
7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
7.2 Europe Recombinant Hepatitis B Vaccine Market Size by Application
7.2.1 Europe Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
7.2.2 Europe Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
7.3 Europe Recombinant Hepatitis B Vaccine Market Size by Country
7.3.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
7.3.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Type
8.1.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Application
8.2.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Hepatitis B Vaccine Market Size by Region
8.3.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Recombinant Hepatitis B Vaccine Market Size by Type
9.1.1 Latin America Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
9.2 Latin America Recombinant Hepatitis B Vaccine Market Size by Application
9.2.1 Latin America Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
9.3 Latin America Recombinant Hepatitis B Vaccine Market Size by Country
9.3.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Type
10.1.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Application
10.2.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Hepatitis B Vaccine Market Size by Country
10.3.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Corporation Information
11.2.2 GlaxoSmithKline Plc Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Plc Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Limited Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Limited Recent Developments
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Corporation Information
11.6.2 Emergent Biosolutions Overview
11.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent Biosolutions Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Serum Institute of India Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
11.9 Hualan Biological Engineering
11.9.1 Hualan Biological Engineering Corporation Information
11.9.2 Hualan Biological Engineering Overview
11.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Biological Engineering Recent Developments
11.10 NCPC
11.10.1 NCPC Corporation Information
11.10.2 NCPC Overview
11.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 NCPC Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NCPC Recent Developments
11.11 China National Biotec Group
11.11.1 China National Biotec Group Corporation Information
11.11.2 China National Biotec Group Overview
11.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 China National Biotec Group Recent Developments
11.12 Dalian Hissen Bio-pharm
11.12.1 Dalian Hissen Bio-pharm Corporation Information
11.12.2 Dalian Hissen Bio-pharm Overview
11.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dalian Hissen Bio-pharm Recent Developments
11.13 Beijing Tiantan Biological
11.13.1 Beijing Tiantan Biological Corporation Information
11.13.2 Beijing Tiantan Biological Overview
11.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Beijing Tiantan Biological Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Hepatitis B Vaccine Industry Chain Analysis
12.2 Recombinant Hepatitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Hepatitis B Vaccine Production Mode & Process
12.4 Recombinant Hepatitis B Vaccine Sales and Marketing
12.4.1 Recombinant Hepatitis B Vaccine Sales Channels
12.4.2 Recombinant Hepatitis B Vaccine Distributors
12.5 Recombinant Hepatitis B Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Hepatitis B Vaccine Industry Trends
13.2 Recombinant Hepatitis B Vaccine Market Drivers
13.3 Recombinant Hepatitis B Vaccine Market Challenges
13.4 Recombinant Hepatitis B Vaccine Market Restraints
14 Key Findings in The Global Recombinant Hepatitis B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
